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A general and convenient method for the synthesis of 2-arylhydrazono-2-cyanoacetamidines, containing 
either a cytisine or tryptamine moiety, or other secondary and primary amines was elaborated. A series of 
5-amino-2-aryl-2H-[1,2,3]-triazole-4-carbonitriles was successfully prepared by oxidation of these 
amidines with copper acetate in pyridine. The screening of the biological activity of the synthesized 
triazoles and amidines have shown that, some of these compounds possess fungicidal activity at 
concentrations of 50 µg/mL against some fungi tested. 
 





Amidines, that can be considered as nitrogen analogs of carboxylic acids, are a structural part of 
numerous compounds of biological interest.1 They were found to possess anti-degenerative,2 anticancer,3 
anti-platelet,4 and antimicrobial5 activity. A number of synthetic inhibitors of serine proteases, NOS 
(nitric oxide synthase) and integrin antagonists have an amidino moiety in the structure.6 Amidines are 
convenient building blocks in organic synthesis; mainly for the synthesis of heterocyclic compounds.7 An 
interesting approach to biologically active compounds concerns the synthesis of compounds with 
fragments of natural compounds. In this respect the amidines are excellent candidates for the synthesis of 
such type of compounds because the amines that are mainly used for their synthesis are widespread in 
nature (aminoacids, peptides, alkaloids).  
This paper presents details on the synthesis of 2-arylhydrazonoacetamidines with various substituents 
at the amidine moiety and the study of their oxidative cyclization to 5-amino-2-aryl-2H-[1,2,3]-triazoles, 
including those containing the fragments of piperazine, tryptamine and the natural alkaloid cytisine. The 
latter were prepared for fungicidal studies in experiments in vitro. 
 
Results and Discussion 
 
There are many synthetic approaches to amidines known from the literature. They are mainly based either 
on addition of amines and ammonia to nitriles8 or on the substitution reactions of imidoyl chlorides, 
imidates and thioimidates with amines.1 The course of the reactions of the first group is mainly governed 
by the electrophilicity of the cyano group and the nucleophilicity of the amines and often requires the use 
of catalysts (Lewis acid at high temperature, CuCl2 with aluminum amide, or the presence of lanthanide 
triflate).9
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There are very few examples of the synthesis of 2-arylhydrazonoacetamidines by reaction of 2-
arylhydrazonomalononitriles with morpholine, piperidine and dimethylamine described in the literature.8 
It was not clear from this report whether this reaction had generality, whether primary amines and 
ammonia could be used in this reaction, and whether various aryl substituted malononitriles reacted with 
amines. Therefore, the scope of this reaction remained to be determined.  
To find a general method for the synthesis of 2-arylhydrazonoacetamidines we have studied the 




Scheme 1  
 
We have found that the optimal conditions for the reaction include the use of ethanol at 70 oC. 
Effective stirring was found to be an important factor to obtain good yields of the products. The use of 
this protocol allowed us to prepare a large series of 2-arylhydrazonoacetamidines 3-8 in good yields 
(Scheme 1). The structures of amidines 3-8 were proved by NMR and mass-spectra. The mass-spectra of 
the prepared compounds contain the peaks corresponding to their molecular weights.  
In principle 2-arylhydrazonoacetamidines can exist in three tautomeric forms A-C (Scheme 2). It is 
interesting to note that a single set of signals corresponding to all proton-containing groups was registered 



































There are no NH proton signals in the 1H NMR spectra of compounds 3-8 that would correspond to 
the hydrazono group. The signals of the amino groups of the amidine fragment are shown as a broad four 
proton singlet for compounds 3 at 6.65 – 7.18 ppm; as a one proton singlet and a two proton singlet for 
compounds 4,5 at 7.15 – 7.42 ppm; and as a two proton singlet for compounds 6-8 at 6.58-6.97 ppm. IR 
spectra of compounds 3-8 show a few broad bands between 3200-3450 cm-1 confirming the presence of 
amino groups. 
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Figure 1 X-Ray of 3-Amino-2-(4-methoxyphenylazo)-3-piperidin-1-yl-acrylonitrile (7а). 
 
The study of single crystals of 3-amino-4-methoxyphenylazo-3-piperidin-1-yl-acrylonitrile 7a 
obtained from EtOH by X-ray analysis (Figure 1) and NMR data showed that for compounds 3-8 
preferred form is the form of isomer C. Furthermore, this compound exists in the form of the E,E-isomer, 
probably because of intramolecular hydrogen bonds as it is shown in Figure 1. It is worth noting that the 
conjugated C=C and N=N bonds are coplanar with a deviation of less than 3 o. It should be noted that the 
replacement of one of the cyano groups in the malononitriles 1 by a carbamoyl function drastically 
decreases the reactivity of the second cyano group and 2-arylhydrazono-2-cyanoacetamides do not react 
with amines. 
We have expanded this method to prepare amidines 10-12 bearing fragments of natural compounds, in 
a yield of 50-88% by reaction of the malononitrile derivatives 1a-h with tryptamine, cytisine and 





Indeed, a large series of 2-arylhydrazonoacetamides 3-8, 10-12 was synthesized. It was found that the 
scope of this reaction is quite broad; ammonia and any primary and secondary amines react with 2-
arylmalononitriles to form 2-arylhydrazonoacetamidines.  
Because of the fact that 1,2,3-triazole derivatives are shown to be interesting objects for testing of 
biological activity10 and 4-cyano-1,2,3-triazoles may be excellent precursor for the different heterocyclic 
derivatives, we made attempts to devise a general method for the synthesis of 2H-1,2,3-triazoles by 
oxidative cyclization of 2-arylhydrazonoacetamidines. One of the purposes of this study was to prepare 
triazoles containing the tryptamine and cytisine moiety.  
The oxidative cyclization of 2-arylhydrazonoacetamidines 4-7 and 10-12 was carried out by a 
modified protocol8 with copper acetate in pyridine at 60 oC under vigorous stirring to form triazoles 13-22 
in good yield (Scheme 4). 
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1H and 13C NMR spectra of the prepared compounds correspond to the proposed structures. In 
contrast to the starting materials 4-7, 10-12, the 1H NMR spectra of the compounds 13-22 do not contain 
the primary amino group proton signals. Furthermore, mass-spectra of these compounds have molecular 





The main feature of the IR spectra of 13,14,17 is the presence of a single intense band at 3360-3380 
сm-1corresponding to the NH group. Indeed the spectral data proved the involvement of primary amino 
groups of compounds 4,5,10 in the process of oxidative cyclization and formation of rather the structures 
13,14,17 than 23.  
1,2,3-Triazoles have found many applications in the pharmaceutical and agricultural industries.10 
Fungicides containing triazole moieties prevent disease and are used to increase the yield.10c  
A number of new compounds were tested for fungicide activity in comparison with the starting 
amidines using the fungi growth inhibition method (Table 1).11 
Table 1 revealed that the nature of the substituent on the aromatic ring and the type of tert-
cycloalkylamino group may have considerable impact on the antifungal activities of the target 
compounds. Of particular importance, a piperidino or cytisine group generally enhances the antifungal 
activity (amidine 7b, 11e-f and triazole 16c, 18b-f). The activity of 18f was even more than 90% against 
Sclerotinia sclerotiorum (K) and Rhizoctonia solani Kuhn (L), therefore it is suitable for further structure 
modification to obtain compounds with high fungicidal activity. The introduction of one or two fluorine 
atoms onto the triazole aromatic ring imparts appreciable antifungal activity (18d and 18e; 18c and 18f). 
On the other hand the introduction of two fluorine atoms on the aromatic nucleus of the amidine group 
decreases the antifungal activity of these compounds (6b and 6c; 7b and 7c; 8a and 8b). 
All the target compounds were found to be inactive against Cercospora rachidicola. All compounds 




In conclusion, a series of new arylhydrazonoacetamidines were synthesized and transformed to 2-aryl-2H-
1,2,3-triazole-5-amines by oxidative heterocyclization. It has been shown that this method allows to 
introduce the fragments of the natural products (tryptamine) or alkaloids (cytisine) into the structure of 
hydrazonoamidines and triazoles. Indeed new general methods for the synthesis of 2-
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arylhydrazonoacetamidines and of 2-aryl-2H-1,2,3-triazole-5-amines have been elaborated. The target 
compounds were screened for antifungal activity and some compounds exhibited an inihibitory effect 
against some fungi tested at concentration of 50 µg/mL. The biological effect is sensitive to structural 
variations of the amidine and triazole fragments, and some structures deserve further derivatisation for 
fungicide development.  
 
Table 1. Results of in vitro fungicide activity determination 
Fungi growth inhibition, % Compd. 
No. A B C D E F G H I J K L 
6b 27.3 46.7 0 11.1 4.8 70.7 70.7 36.4 14.3 13.6 - - 
6c 18.2 0 0 0 0 36.6 51.6 36.4 0 13.6 - - 
7b 27.3 46.7 0 11.1 4.8 61.0 59.4 31.4 14.3 22.7 - - 
7c 9.1 26.7 0 0 0 12.2 53.1 36.4 28.6 13.6 - - 
8a 27.3 46.7 6.7 0 0 68.3 56.3 36.4 0 22.7 - - 
8b 9.1 26.7 0 11.1 4.8 9.8 56.3 31.8 14.3 13.6 - - 
10d 45.5 46.7 0 33.3 19 56.1 64.1 45.5 14.3 27.3 - - 
10e 27.3 20.0 40 33.3 4.8 41.5 51.6 45.5 14.3 18.2 - - 
11e 18.2 40 0 11.1 9.5 63.4 35.6 40.9 0 13.6 - - 
11f 45.5 73.3 6.7 22.1 33.3 61.0 59.4 50.0 28.6 31.4 - - 
15e 18.2 20 0 22.2 4.8 24.4 43.8 40.9 0 13.6 - - 
16c 36.4 20 6.7 44.4 23.8 70.7 67.2 68.2 0 40.9 - - 
17f 45.5 26.7 0 33.3 9.5 36.6 40.6 59.1 14.3 27.3 - - 
18b - 37.1 - 28.0 - 5.9 - - - - 51.9 55.6 
18c - 40.0 - 36.0 - 0 - - - - 63.0 46.7 
18d - 54.3 - 16.0 - 0 - - - - 22.2 24.4 
18e - 65.7 - 56.0 - 17.6 - - - - 88.9 68.9 
18f 45.5 57.6 0 60.2 42.9 71.7 65.6 45.5 28.6 54.5 92.6 95.6 
A –Cercospora beticolla; B –Fusarium oxysporum f. cucumerinum; C –Cercospora rachidicola; D – 
Alternaria solani; E - Gibberella zeae; F – Physalospora piricola; G –Pellicularia sasakii; H - 
Colletotrichum lagenarium; I – Verticilium  dahliae; J – Phytophthora infestans; K –Sclerotinia 




General Procedures. Melting points were measured with a SNP Stuart melting points apparatus and are 
uncorrected. Infrared spectra were recorded on a Specord IR-75 in potassium bromide pellets. Mass spectra were 
obtained by using electron impact ionization techniques on a Varian MAT 311A spectrometer (ionizing voltage of 
70eV). 1H and 13C NMR spectra were recorded on a «Bruker WP-250» (250 MHz for 1Н) and Bruker DRX-400 
(400 МHz for 1H and 100 MHz for 13C). The solvent for the NMR was DMSO-d6. Chemical shifts (δ) are reported 
in ppm relative to TMS. Crystallographic data for the structure reported in this paper were measured with an 
Xcalibur 3 CCD (graphite monochromator, MoKa) and have been deposited with the Cambridge Crystallographic 
Data Centre as supplementary publication no. CCDC 677318. All reactions were monitored by thin layer 
chromatography, carried out on silica gel Sorbfil UV-254 sheets. Yields refer to chromatographically and 
spectroscopically pure material. All chemicals were used as supplied by Sigma-Aldrich and Acros. Pyridine and 
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General procedure for the synthesis of arylhydrazonoacetamidine 3-8, 10-12 
A mixture of 0.01 mol hydrazone 1 and 1.3 mol of the corresponding amine in 50 mL ethanol was stirred and was 
heated at 70 °C for about 10 h (TLC). Then, the reaction mixture was poured onto crushed ice. The product which 
separated was collected by filtration and was crystallized from ethanol.  
3,3-Diamino-2-(4-methoxyphenylazo)-acrylonitrile (3а). Yellow solid (1.52 g, 70%); mp 242-243 °С; IR (KBr): 
νmax 3450, 3420, 3350, 3250, 3200 (NH), 3000, 2930, 2900, 2830 (CH), 2180 (CN) cm-1; 1Н NMR (250 MHz): δ 
3.78 (s, 3Н, ОMe), 6.65-6.85 (m, 6Н, 2NH2+H-Ar), 7.47 (d, 2H, H-Ar, J = 8.8 Hz); MS: m/z (%) 217 (М+, 62.5%); 
Anal. Calcd. for C10H11N5O: C, 55.29; H, 5.10; N, 32.24. Found: C, 55.51; H, 5.23; N, 32.45.  
3,3-Diamino-2-phenylazo-acrylonitrile (3b). Yellow solid (1.20 g, 64%); mp 239-241 °С; IR (KBr): νmax 3420, 
3410, 3350, 3250, 3200 (NH), 2180 (CN) cm-1; 1Н NMR (250 MHz): δ 6.97 (br s, 4Н, 2NH2), 7.06 (t, 1Н, H-Ar, J 
= 7.4 Hz), 7.24 (t, 2Н, H-Ar, J = 7.3 Hz), 7.49 (d, 2Н, H-Ar, J = 7.4 Hz); MS: m/z (%) 187 (М+, 31.6%); Anal. 
Calcd. for С9Н9N5: C, 57.74; H, 4.85; N, 37.41. Found: C, 57.53; H, 4.71; N, 37.63.  
3,3-Diamino-2-(4-chlorophenylazo)-acrylonitrile (3с). Yellow solid, (1.35 g, 61%); mp 249-251 °С; IR (KBr): 
νmax 3420, 3410, 3350, 3250, 3200(NH), 2180 (CN) cm-1; 1Н NMR (400 MHz): δ 7.18 (br s, 4Н, 2NH2), 7.29 and 
7.57 (AA′XX′, 4H, H-Ar, J = 8.8 Hz); 13C NMR (100 MHz): δ 91.4, 115.4, 121.9 (2С), 128.5 (2С), 129.1, 152.3, 
161.3; MS: m/z (%) 221 (М+, 39.5%); Anal. Calcd. for С9Н8ClN5: C, 48.77; H, 3.64; N, 31.60. Found: C, 48.89; H, 
3.81; N, 31.45.  
3-Amino-2-(4-methoxyphenylazo)-3-methylaminoacrylonitrile (4a). Yellow crystals (2.08 g, 90%); mp 313-315 
°С; IR (KBr): νmax 3440, 3315, 3260, 3175, 3100 (NH), 2950, 2930, 2910 2825 (CH), 2180 (CN) cm-1; 1Н NMR 
(250 MHz): δ 2.93 (d, 3Н, Me, J = 4.8 Hz), 3.76 (s, 3H, OMe), 7.15 (br s, 2Н, NH2), 7.35-7.45 (m, 1Н, NH), 6.80 
and 7.45 (AA′XX′, 4H, H-Ar, J = 8.8 Hz); MS: m/z (%) 231 (М+, 67.6%); Anal. Calcd. for C11H13N5O: C, 57.13; H, 
5.67; N, 30.28. Found: C, 57.45; H, 5.75; N, 30.45. 
3-Amino-3-methylamino-2-phenylazoacrylonitrile (4b). Yellow crystals, (1.33 g, 66%); mp 225-227 °С; IR 
(KBr): νmax 3430, 3330, 3260 (NH), 2180 (CN) cm-1; 1Н NMR (250 MHz): δ 2.92 (d, 3Н, Me, J = 4.5 Hz), 7.03 (t, 
1Н, H-Ar, J = 7.3 Hz), 7.3-7.4 (m, 3Н, H-Ar+NH), 7.49 (d, 2Н, H-Ar, J = 8.0 Hz), 7.56 (br s, 2Н, NH2); MS: m/z 
(%) 201 (М+, 41.6%); Anal. Calcd. for C10H11N5: C, 59.69; H, 5.51; N, 34.80. Found: C, 59.41; H, 5.83; N, 35.03. 
3-Amino-2-(4-chlorophenylazo)-3-methylaminoacrylonitrile (4c). Yellow crystals (2.02 g, 86%); mp 219-220 
°С; 1Н NMR (400 MHz): δ 2.90 (d, 3Н, Me, J = 4.5 Hz), 7.32 and 7.57 (AA′XX′, 4H, H-Ar, J = 9.0 Hz), 7.60 (br s, 
2H, NH2), 7.84 (q, 1H, NH, J = 4.5 Hz); 13C NMR (100 MHz): δ 28.6, 91.5, 115.6, 121.8 (2С), 128.4 (2С), 128.6, 
152.5, 160.0; MS: m/z (%) 235 (М+, 35.3%); Anal. Calcd. for C10H10ClN5: C, 50.96; H, 4.28; N, 29.72. Found: C, 
50.71; H, 4.36; N, 28.03. 
3-Amino-3-methylamino-2-(4-nitrophenylazo)-acrylonitrile (4d). Yellow crystals (2.10 g, 85%); mp 290-291 
°С; 1Н NMR (400 MHz): δ 2.94 (d, 3Н, Me, J = 4.5 Hz), 7.68 and 8.12 (AA′XX′, 4H, H-Ar, J = 9.2 Hz), 8.00 (br s, 
2H, NH2), 8.15 (q, 1H, NH, J = 4.5 Hz); 13C NMR (100 MHz): δ 28.9, 95.5, 114.5, 120.1 (2С), 124.7 (2С), 142.7, 
159.1, 159.5; Anal. Calcd. for C10H10N6O: C, 48.78; H, 4.09; N, 34.13. Found: C, 48.55; H, 4.26; N, 34.33. 
3-Amino-3-cyclohexylamino-2-(4-methoxyphenylazo)-acrylonitrile (5а). Yellow crystals (2.48 g, 83%); mp 
173-174 °С; IR (KBr) νmax 3430, 3330, 3210, 3160 (NH), 2940, 2860, 2830 (CH), 2180 (CN) cm-1; 1Н NMR (250 
MHz): δ 1.20-2.0 (m, 10Н, 5СН2), 3.60-3.75 (m, 1Н, СН), 3.77 (s, 3H, OMe), 6.75-6.80 (m, 1H, NH), 7.25 (br s, 
2Н, NH2), 6.82 and 7.40 (AA′XX′, 4H, H-Ar, J = 8.7 Hz); MS: m/z (%) 299 (М+, 49.1%); Anal. Calcd. for 
С16Н21N5О: C, 64.19; H, 7.07; N, 23.39. Found: C, 64.41; H, 7.23; N, 23.54. 
3-Amino-3-cyclohexylamino-2-phenylazo-acrylonitrile (5b). Yellow crystals (2.25 g, 84%); mp 181-182 °С; 1Н 
NMR (250 MHz): δ 1.02-2.04 (m, 10Н, 5СН2), 3.83-4.09 (m, 1Н, СН), 7.17 (t, 1Н, H-Ar, J = 7.3 Hz), 7.37 (t, 2Н, 
H-Ar, J = 7.2 Hz), 7.74 (d, 2Н, H-Ar, J = 7.3 Hz), 9.15 (d, 1Н, NH, J = 8.5 Hz), 9.6 (br s, 2Н, NH2); MS: m/z (%) 
269 (М+, 35.9); Anal. Calcd. for С15Н19N5: C, 66.89; H, 7.11; N, 26.00. Found: C, 66.59; H, 6.89; N, 26.23. 
3-Amino-2-(4-chlorophenylazo)-3-cyclohexylaminoacrylonitrile (5с). Yellow crystals (1.90 g, 63%); mp 185-
186 °С; 1Н NMR (250 MHz): δ 1.10-2.00 (m, 10Н, 5СН2), 3.55-3.75 (m, 1Н, СН), 6.97 (d, 1Н, NH, J = 9.0 Hz), 
7.42 (br s, 2Н, NH2), 7.24 and 7.46 (AA′XX′, 4H, H-Ar, J = 8.6 Hz); MS: m/z (%) 303 (М+, 53.7%); Anal. Calcd. 
for C15H18ClN5: C, 59.31; H, 5.97; N, 23.05. Found: C, 59.55; H, 6.13; N, 23.33. 
3-Amino-3-cyclohexylamino-2-(4-nitrophenylazo)-acrylonitrile (5d). Yellow crystals (2.15 g, 68%); mp 260-
261 °С; 1Н NMR (400 MHz); δ 1.20-1.50 (m, 5Н, СН2), 1.55-1.65 (m, 1Н, СН2), 1.70-1.80 (m, 2Н, СН2), 1.80-
1.90 (m, 2Н, СН2), 3.60-3.70 (m, 1Н, СН), 7.66 and 8.12 (AA′XX′, 4H, H-Ar, J = 9.0 Hz), 7.82 (d, 1Н, NH, J = 9.0 
Hz), 7.99 (s, 2Н, NH2); 13C NMR (100 MHz): δ 24.6, 24.8 (2C), 31.7 (2C), 59.7, 95.9, 114.6, 120.2 (2С), 124.7 
(2С), 142.7, 157.7, 159.0; Anal. Calcd. for C15H18N6O2: C, 57.31; H, 5.77; N, 26.73. Found: C, 57.38; H, 5.91; N, 
27.03.  
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3-Amino-2-(4-methoxyphenylazo)-3-pyrrolidin-1-yl-acrylonitrile (6a). Yellow crystals (2.27 g, 84 %); mp 195-
196 °С; IR (KBr): νmax 3450, 3340, 3190 (NH), 2970, 2940, 2880, 2840 (CH), 2180 (CN) cm-1; 1Н NMR (400 
MHz): δ 1.90-1.95 (m, 4Н, 2СН2), 3.61-3.65 (m, 4Н, 2СН2), 3.76 (s, 3H, OMe), 7.12 (br s, 2Н, NH2), 6.89 and 7.44 
(AA′XX′, 4H, H-Ar, J = 9.0 Hz); 13C NMR (100 MHz): δ 24.8 (2C), 49.5 (2C), 55.2, 91.5, 113.9 (2С), 117.5, 121.5 
(2С), 147.7, 157.4, 158.3; MS: m/z (%) 271 (М+, 59.2%); Anal. Calcd. for C14H17N5O: C, 61.98; H, 6.32; N, 25.81. 
Found: C, 61.74; H, 6.03; N, 26.06. 
3-Amino-2-(4-fluorophenylazo)-3-pyrrolidin-1-yl-acrylonitrile (6b). Yellow crystals (2.02 g, 78%); mp 190-191 
°С; 1Н NMR (250 MHz): δ 1.95-2.05 (m, 4Н, 2СН2), 3.60-3.78 (m, 4Н, 2СН2), 6.9-7.1 (m, 4H, H-Ar+NH2), 7.42-
7.55 (m, 2H, H-Ar); Anal. Calcd. for C13H14FN5: C, 60.22; H, 5.44; N, 27.01. Found: C, 59.85; H, 5.25; N, 27.36.  
3-Amino-2-(3,5-difluorophenylazo)-3-pyrrolidin-1-yl-acrylonitrile (6c). Yellow crystals (2.5 g, 85%); mp 240-
241 °С; IR (KBr): νmax 3420, 3400, 3300 (NH), 2970, 2950, 2920, 2870 (CH), 2190 (CN) cm-1; 1Н NMR (250 
MHz): δ 1.90-2.10 (m, 4Н, 2СН2), 3.60-3.80 (m, 4Н, 2СН2), 6.59 (tt, 1H, H-Ar, J = 8.9, 2.1 Hz), 7.0-7.15 (m, 2H, 
H-Ar), 7.31 (br s, 2Н, NH2); Anal. Calcd. for C13H13F2N5: C, 56.31; H, 4.73; N, 25.26. Found: C, 56.16; H, 4.95; N, 
25.52  
3-Amino-2-(4-nitrophenylazo)-3-pyrrolidin-1-yl-acrylonitrile (6d). Yellow crystals (2.4 g, 85%); mp 259-260 
°С; IR (KBr) νmax 3420, 3400, 3300 (NH), 2970, 2950, 2920, 2870 (CH), 2190 (CN) cm-1; 1Н NMR (250 MHz): δ 
1.95-2.10 (m, 4Н, 2СН2), 3.65-3.75 (m, 4Н, 2СН2), 7.54 (br s, 2Н, NH2), 7.57 and 8.10 (AA′XX′, 4H, H-Ar, J = 9.2 
Hz); 13C NMR: (100 MHz): δ 24.9 (2C), 50.5 (2C), 96.8, 115.7, 120.1 (2С), 124.7 (2С), 142.8, 157.6, 159.0; Anal. 
Calcd. for C13H14N6O2: C, 54.54; H, 4.93; N, 29.35. Found: C, 54.35; H, 5.17; N, 29.61.  
Amino-2-(4-methoxyphenylazo)-3-piperidin-1-yl-acrylonitrile (7а). Yellow crystals (1.85 g, 65%); mp 134-136 
°С; IR (KBr): νmax 3415, 3315, 3205, 3160 (NH), 2940, 2860, 2840 (CH), 2180 (CN) cm-1; 1Н NMR (250 MHz): δ 
1.70 (br s, 6H, 3CH2), 3.57 (br s, 4H, 2CH2), 3.78 (s, 3H, OMe), 7.18 (br s, 2H, NH2), 6.83 and 7.43 (AA′XX′, 4H, 
H-Ar, J = 9.2 Hz); MS: m/z (%) 285 (М+, 56.9%); Anal. Calcd. for C15H19N5O: C, 63.14; H, 6.71; N, 24.54. Found: 
C, 62.88; H, 6.89; N, 24.68.  
3-Amino-2-(4-fluorophenylazo)-3-piperidin-1-yl-acrylonitrile (7b). Yellow crystals (1.70 g, 62%); mp 200-201 
°С; 1Н NMR (250 MHz): δ 1.70 (br s, 6Н, 3СН2), 3.59 (br s, 4Н, 2СН2), 7.02 (t, 2H, H-Ar, J = 8.9 Hz), 7.32 (br s, 
2H, NH2), 7.46 (dd, 2H, H-Ar, J = 9.0, 5.0 Hz); Anal. Calcd. for C14H16FN5: C, 61.52; H, 5.90; N, 25.62. Found: C, 
61.29; H, 5.76; N, 25.90.  
3-Amino-2-(3,5-difluorophenylazo)-3-piperidin-1-yl-acrylonitrile (7c). Yellow crystals (1.60 g, 55%); mp 220-
221 °С; IR (KBr): νmax 3410, 3310, 3210 (NH), 2960, 2940, 2920, 2865 (CH), 2180 (CN) cm-1; 1Н NMR (250 
MHz): δ = 1.71 (br s, 6Н, 3СН2), 3.61 (br s, 4Н, 2СН2), 6.60 (tt, 1H, H-Ar, J = 8.9, 2.2 Hz), 7.05-7.10 (m, 2H, H-
Ar), 7.65 (br s, 2H, NH2); Anal. Calcd. for C14H15F2N5: C, 57.72; H, 5.19; N, 24.04. Found: C, 57.53; H, 5.27; N, 
24.37.  
3-Amino-2-(4-fluorophenylazo)-3-morpholin-4-yl-acrylonitrile (8a). Yellow crystals (1.93 g, 70%); mp 198-200 
°С; 1Н NMR (250 MHz): δ 3.55-3.75 (m, 8Н, 4СН2), 7.04 (br s, 2H, NH2), 7.25 (t, 2H, H-Ar, J = 8.5 Hz), 7.40-7.50 
(m, 4H, H-Ar+NH2); Anal. Calcd. for C13H14FN5O: C, 56.72; H, 5.13; N, 25.44. Found: C, 56.95; H, 5.32; N, 25.64.  
3-Amino-2-(3,5-difluorophenylazo)-3-morpholin-4-yl-acrylonitrile (8b). Yellow crystals (1.90 g, 65%); mp 
119-220 °С; IR (KBr): νmax 3410, 3300, 3200 (NH), 2980, 2920, 2860 (CH), 2190 (CN) cm-1; 1Н NMR (250 MHz): 
δ 3.60-3.80 (m, 8Н, 4СН2), 6.63 (tt, 1H, H-Ar, J = 9.0, 2.3 Hz), 7.05-7.15 (m, 2H, H-Ar), 7.81 (br s, 2H, NH2); 
Anal. Calcd. for C13H13F2N5O: C, 53.24; H, 4.47; N, 23.88. Found: C, 52.95; H, 4.63; N, 24.12.  
3-Amino-3-[2-(1H-indol-3-yl)-ethylamino]-2-(4-methoxyphenylazo)-acrylonitrile (10a). Yellow crystals (3.15 
g, 87%); mp 161-162 °С; IR (KBr): νmax 3440, 3310, 3240 (NH), CH 2910, 2865, 2840, CN 2180 cm-1; 1Н NMR 
(250 MHz): δ 3.06 (t, 2Н, СН2, J = 7.2 Hz), 3.61 (dt, 2Н, СН2, J = 6.5, 7.2 Hz), 3.77 (s, 3Н, ОMe), 6.81 (d, 2Н, H-
Ar, J = 9.3 Hz), 6.99 (t, 2H, H-Ind, J = 7.8 Hz), 7.06 (s, 1H, H-Ind), 7.23 (m, 3H, NH+NH2), 7.34 (m, 3H, H-Ar+H-
Ind), 7.57 (d, 1H, H-Ind, J = 7.5 Hz), 10.7 (s, 1H, NH); MS: m/z (%) 360 (М+, 41.15 %); Anal. Calcd. for 
С20Н20N6О: C, 66.65; H, 5.59; N, 23.32. Found: C, 66.38; H, 5.78; N, 23.53.  
3-Amino-2-(4-chlorophenylazo)-3-[2-(1H-indol-3-yl)-ethylamino]-acrylonitrile (10b). Yellow crystals (3.1 g, 
87%); mp 176-178 °С; IR (KBr): νmax 3440, 3310, 3240 (NH), 2910, 2865, 2840 (CH), 2180 (CN) cm-1; 1Н NMR 
(400 MHz): δ 3.02 (t, 2Н, СН2, J = 7.6 Hz), 3.62 (br s, 2Н, СН2), 6.99 (t, 1Н, H-Ind, J = 6.8 Hz), 7.03 (t, 1H, H-Ind, 
J = 7.8 Hz), 7.16 (s, 1H, H-Ind), 7.24 (d, 2H, H-Ar, J = 8.0 Hz), 7.33-7.38 (3H, m, H-Ar+H-Ind), 7.56 (d, 1H, H-
Ind, J = 7.3 Hz), 7.68-7.73 (m, 3H, NH+NH2), 10.9 (s, 1H, NH); MS: m/z (%) 364 (М+, 17.6 %); Anal. Calcd. for 
С19Н17ClN6: C, 62.55; H, 4.70; N, 23.03. Found: C, 62.31; H, 4.87; N, 23.31.  
4-{2-Amino-1-cyano-2-[2-(1H-indol-3-yl)-ethylamino]-vinylazo}-benzoic acid ethyl ester (10c). Colorless 
crystals (3.00 g, 80%); mp 215-216 °С; IR (KBr): νmax 3440, 3310, 3240 (NH), 2910, 2865, 2840 (CH), 2180 (CN) 
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cm-1; 1Н NMR (400 MHz): δ 1.31 (t, 3H, CH3, J = 7.2 Hz), 3.06 (t, 2Н, СН2, J = 7.6 Hz), 3.61 (dt, 2Н, СН2, J = 6.5, 
7.6 Hz), 4.28 (q, 2Н, CH2, J = 7.2 Hz), 6.99 (t, 2Н, H-Ind, J = 7.8 Hz), 7.06 (t, 2H, H-Ind, J = 8.0 Hz), 7.24 (s, 1H, 
H-Ind), 7.36 (d, 1H, H-Ind, J = 8.4 Hz), 7.54 and 7.89 (AA'XX', 4H, H-Ar, J = 8.8 Hz ), 7.62 (d, 1H, H-Ind, J = 8.0 
Hz), 7.70-7.90 (brs, 3H, NH2+NH) 10.7 (s, 1H, NH); 13C (100 MHz): δ 14.2, 24.4, 42.0, 60.3, 93.4, 110.8, 111.4, 
115.1 (2С), 118.3, 118.4, 120.0 (2С), 121.0, 123.1, 125.1, 127.1, 130.0, 136.2, 157.2, 159.0, 165.7; MS: m/z (%) 
402 (М+, 34.2%); Anal. Calcd. for С22Н22N6О2: C, 65.66; H, 5.51; N, 20.88. Found: C, 65.41; H, 5.43; N, 20.67.  
3-Amino-2-(4-flurophenylazo)-3-[2-(1H-indol-3-yl)-ethylamino]-acrylonitrile (10d). Yellow crystals (2.78 g, 
80%); mp 218-220 °С; 1Н NMR (400 MHz): δ 3.02 (t, 2Н, СН2, J = 7.6 Hz), 3.62 (br s, 2Н, СН2), 6.8-7.2 (m, 4Н, 
H-Ar+H-Ind), 7.2 (s, 1H, H-Ind), 7.36 (d, 1H, H-Ind, J = 7.5 Hz), 7.4-7.7 (m 6H, H-Ar+H-Ind+NH+NH2), 10.89 (s, 
1H, NH); 13C (100 MHz,): δ 24.6, 42.0, 90.9, 110.9, 111.4, 115.2 (d, 2С, 2JCF = 22.2 Hz), 115.9 118.4, 121.0, 121.6 
(d, 2C, 3JCF = 7.9 Hz), 123.1, 127.0, 136.2, 150.4, 159.3, 160.0 (d, 1JCF = 240 Hz); Anal. Calcd. for С19Н17FN6: C, 
65.51; H, 4.92; N, 24.12. Found: C, 65.32; H, 4.71; N, 24.35.  
3-Amino-2-(3,5-difluorophenylazo)-3-[2-(1H-indol-3-yl)-ethylamino]-acrylonitrile (10e). Yellow crystals (1.8 
g, 50%); mp 210-212 °С; 1Н NMR (400 MHz): δ 3.08 (t, 2Н, СН2, J = 7.0 Hz), 3.72 (br s, 2Н, СН2), 6.72 (t, 1H, H-
Ar, J = 7.0 Hz), 6.80-7.2 (m, 5Н, H-Ind+H-Ar+NH2), 7.32 (d, 1H, H-Ind, J = 8.0 Hz), 7.50-7.70 (m, 3H, H-Ind+H-
Ar), 7.8 (t, 1H, NH, J = 6.9 Hz), 10.7 (brs, 1H, NH); 13C (100 MHz,): δ 24.4, 42.1, 92.6, 99.3 (t, 2JCF = 27.2 Hz), 
102.9 (d, 2C, 2JCF = 25.5 Hz), 110.9, 111.4, 115.1, 118.3, 118.4, 121.0, 123.0, 127.1, 136.2, 156.8 (t, 3JCF = 9.6 Hz), 
158.9, 163.0 (dd, 2C, 1JCF = 242.3, 3JCF = 15.0 Hz); Anal. Calcd. for С19Н16F2N6: C, 62.29; H, 4.40; N, 22.94. 
Found: C, 62.05; H, 4.53; N, 23.14. 
3-Amino-2-(4-nitrophenylazo)-3-[2-(1H-indol-3-yl)-ethylamino]-acrylonitrile (10f). Yellow crystals (3.1 g, 
63%); mp 308-310 °С; 1Н NMR (400 MHz): δ 3.03 (t, 2Н, СН2, J = 7.2 Hz), 3.66 (t, 2Н, СН2), 6.98 (t, 1Н, H-Ind, J 
= 6.8 Hz), 7.08 (t, 1H, H-Ind, J = 7.2 Hz), 7.24 (s, 1H, H-Ind), 7.36 (d, 2H, H-Ar, J = 8.0 Hz), 7.33-7.38 (3H, m, H-
Ar+H-Ind), 7.56 (d, 1H, H-Ind, J = 7.3 Hz), 7.68-7.73 (m, 3H, NH+NH2), 10.9 (s, 1H, NH); 13C (100 MHz,): δ 
24.2, 42.1, 95.7, 110.7, 111.4, 114.5, 118.3 (2C), 120.1 (2C), 121.0, 123.2, 124.7 (2C), 127.0, 136.2, 142.7, 158.6, 
159.0; Anal. Calcd. for С19Н17ClN6: C, 62.55; H, 4.70; N, 23.03. Found: C, 62.31; H, 4.87; N, 23.31.  
3-Amino-2-(4-methoxyphenylazo)-3-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-
a][1,5]diazocin-3-yl)-acrylonitrile (11a). Yellow crystals (2.93 g, 75%); mp 183-185 °С; 1Н NMR (250 MHz): δ 
1.99 and 2.07 (AA′ВВ′, 2H, СН2, J = 12.8 Hz), 2.58 (br s, 1Н, CH), 3.23 (br s, 1Н, CH), 3.39 (d, 1Н, CH, J = 13.1 
Hz), 3.54 (d, 1Н, CH, J = 13.1 Hz), 3.68-3.72 (m, 1Н, CH), 3.76 (s, 3Н, ОMe), 4.02 (d, 1Н, CH, J = 13.2 Hz), 4.30 
(d, 1Н, CH, J = 13.8 Hz), 4.42 (d, 1Н, CH, J = 15.3 Hz), 6.12 (d, 1Н, H-Ar, J = 6.5 Hz), 6.20 (d, 1Н, H-Ar, J = 9.0 
Hz), 7.23 (br s, 2H, NH2), 7.26 (dd, 1H, H-Ar, J = 9.0, 6.5 Hz), 6.84 and 7.42 (AA′XX′, 4H, H-Ar, J = 9.0 Hz); 13C 
(100 MHz): δ 24.94, 27.0, 33.9, 47.8, 53.0, 55.2, 55.4, 92.1, 104.8, 113.9 (2С), 116.2, 117.1, 121.8 (2С), 139.0, 
147.4, 149.4, 157.8, 162.38, 162.7; MS: m/z (%) 390 (М+, 7.5%); Anal. Calcd. for С21Н22N6О2: C, 64.60; H, 5.68; 
N, 21.52. Found: C, 64.43; H, 5.47; N, 21.63.  
3-Amino-3-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-a][1,5]diazo-cin-3-yl)-2-phenylazo-
acrylonitrile (11b). Colorless crystals (3.13 g, 87%); mp 163-165 °С; 1Н NMR (250 MHz): δ 1.97 and 2.03 
(AA′ВВ′, 2H, СН2, J = 12.5 Hz), 2.61 (br s, 1H, CH), 3.24 (s, 1H, CH), 3.40 (d, 1H, CH, J = 13.6 Hz), 3.55 (d, 1H, 
CH, J = 12.8 Hz), 3.70 (dd, 1H, CH, J = 15.8, 6.3 Hz), 4.0-4.08 (m, 1H, CH), 4.33 (d, 1H, CH, J = 13.2 Hz), 4.43 
(d, 1H, CH, J = 16.1 Hz), 6.12 (d, 1H, H-Ar, J = 7.0 Hz), 6.22 (d, 1H, H-Ar, J = 8.8 Hz), 7.05 (t, 1H, H-Ar, J = 7.0 
Hz), 7.25-7.20 (m, 3H, H-Ar), 7.27 (d, 2H, H-Ar, J = 8.5 Hz), 7.30 (br s, 2H, NH2); MS; (%) m/z 360 (М+, 9.6%); 
Anal. Calcd. for С20Н20N6О: C, 66.65; H, 5.59; N, 23.32. Found: C, 66.89; H, 5.71; N, 23.12.  
4-[2-Amino-1-cyano-2-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-a][1,5]diazocin-3-yl)-
vinylazo]-benzoic acid ethyl ester (11c). Yellow crystals 3.00 g (70%); mp 245-246 °С; 1Н NMR (250 MHz): δ 
1.13 (t 3H, Me, J = 7.1 Hz), 1.96 and 2.05 (AA′ВВ′, 2H, CH2, J = 12.8 Hz), 2.60 (br s, 1H, CH), 3.30 (d, 1H, CH, J 
= 8.3 Hz), 3.43 (d, 1H, CH, J = 13.2 Hz), 3.58 (dd, 1H, CH, J = 10.7), 3.69 (dd, 1H, CH, J = 15.4, 15.2 Hz), 4.0 (d, 
1H, CH, J = 13.2 Hz), 4.26-4.31 (m, 3H, CH), 4.37 (d, 1H, CH, J = 15.4 Hz), 6.19 (1H, d, H-Ar, J = 7.0 Hz), 6.24 
(d, 1H, H-Ar, J = 9.0 Hz), 7.32 (dd, H-Ar, J = 9.0, 7.0 Hz), 7.50 and 7.88 (AA′XX′, 4H, H-Ar, J = 8.7 Hz), 7.79 (br 
s, 2H, NH2); MS: m/z 432 (М+, 15.3%); 13C NMR (100 MHz): δ 14.2, 24.8, 27.0, 33.9, 47.7, 53.0, 55.5, 60.3, 94.4, 
104.8, 116.0, 116.3, 120.2 (2С), 125.7, 130.0 (2С), 139.0, 149.0, 156.9, 162.1, 162.5, 165.6; MS: m/z (%) 432 (М+, 
13.2); Anal. Calcd. for C23H24N6O3: C, 63.88; H, 5.59; N, 19.43. Found: C, 63.86; H, 5.70; N, 19.61. 
3-Amino-2-(4-chlorophenylazo)-3-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-a][1,5]diazocin-
3-yl)-acrylonitrile (11d). Yellow crystals (3.7 g, 93%); mp 170-171 °С; 1Н NMR (400 MHz): δ 2.00 and 2.11 (AB, 
2H, CH2, J = 15.0 Hz), 2.61 (s, 1H, CH), 3.24 (s, 1H, CH), 3.41 (d, 1H, CH, J = 15.0 Hz), 3.56 (dd, 1H, CH, J = 
13.0, 12.7 Hz), 3.69 (dd, 1H, CH, J = 15.5, 14.3 Hz), 4.02 (m, 1H, CH), 4.31 (d, 1H, CH, J = 13.5 Hz), 4.42 (d, 1H, 
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CH, J = 15.7 Hz), 6.12 (dd, 1H, CH, J = 6.5, 1.0 Hz), 6.21 (1H, dd, CH, J = 9.0, 1.0 Hz), 7.25 (dd, 1H, CH, J = 9.0, 
6.5 Hz), 7.25 and 7.43 (AA′ХХ′, 4Н, H-Ar, J = 8.8 Hz), 7.41 (s, 2H, NH2); Anal. Calcd. for С20Н19ClN6О: C, 60.84; 
H, 4.85; N, 21.28. Found: C, 60.78; H, 5.15; N, 21.40.  
3-Amino-2-(4-fluorophenylazo)-3-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-a][1,5]diazocin-
3-yl)-acrylonitrile (11e). Yellow crystals (3.33 g, 88%); mp 173-175 °С; 1Н NMR (250 MHz): δ 1.99 and 2.10 
(AA′ВВ′, 2H, СН2, J = 14.1 Hz), 2.49 (br s, 1Н, CH), 3.26 (br s, 1Н, CH), 3.34-3.60 (m, 2Н, CH), 3.70 (dd, 1Н, 
CH, J = 16.0, 6.5 Hz), 3.97-4.10 (m, 1Н, CH), 4.31 (d, 1Н, CH, J = 13.2 Hz), 4.42 (d, 1Н, CH, J = 15.8 Hz), 6.12 
(d, 1Н, H-Ar, J = 7.0 Hz), 6.22 (d, 1Н, H-Ar, J = 9.0 Hz), 6.96-7.09 (m, 2Н, H-Ar), 7.26 (dd, 1Н, H-Ar, J = 9.0, 7.0 
Hz), 7.33 (brs, 2Н, NH2), 7.42-7.52 (m, 2Н, H-Ar); 13С NMR (100 MHz): δ 24.8, 26.9, 33.9, 47.7, 52.9, 55.4, 92.6 
104.8, 115.3 (d, 2C, 2JCF = 22.2 Hz), 116.2, 116.6, 122.0 (d, 2C, 3JCF = 8.1 Hz), 139.0, 149.2, 150.1, 160.3 (d, 1JCF = 
241 Hz), 162.1, 162.7; MS: m/z (%) 378 (М+, 9.4%); Anal. Calcd. for С20Н19FN6О: C, 63.48; H, 5.06; N, 22.21. 
Found: C, 63.69; H, 5.21; N, 22.12.  
3-Amino-2-(2,4-dichlorophenylazo)-3-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-metha-no-pyrido[1,2-
a][1,5]diazocin-3-yl)-acrylonitrile (11f). Yellow crystals (3.52 g, 82%); mp 223-224 °С; 1Н NMR (250 MHz): δ 
2.04 and 2.17 (AA′ВВ′, 2H, CH2, J = 12.5 Hz), 2.62 (br s, 1H, CH), 3.26 (br s, 1H, CH), 3.4-3.5 (m, 1H, CH), 3.57 
(d, 1H, CH, J = 11.5 Hz), 3.68 (dd, 1H, CH, J = 15.5, 6.3 Hz), 4.0-4.1 (m, 1H, CH), 4.34 (d, 1H, H-Ar, J = 13.8 
Hz), 4.43 (d, 1H, CH, J = 15.8 Hz), 6.13 (d, 1H, H-Ar, J = 6.8 Hz), 6.23 (d, 1H, H-Ar, J = 8.0 Hz), 7.15-7.3 (m, 2H, 
H-Ar), 7.34 (d, 1H, H-Ar, J = 2.0 Hz), 7.49 (d, 1H, H-Ar, J = 8.5 Hz), 7.6 (br s, 1H, NH2); MS: m/z (%) 428 (М+, 
9.5%); Anal. Calcd. for C20H18Cl2N6O: C, 55.96; H, 4.23; N, 19.58. Found: C, 56.16; H, 4.45; N, 19.39.  
3-Amino-2-(3,5-difluorophenylazo)-3-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-
a][1,5]diazocin-3-yl)-acrylonitrile (11g). Yellow crystals (2.45 g, 62%); mp 257-258 °С; 1Н NMR (250 MHz): δ 
2.05 and 2.11 (AA′ВВ′, 2H, CH2, J = 12.5 Hz), 2.66 (br s, 1H, CH), 3.30 (d, 1H, CH, J = 13.8 Hz), 3.45 (d, 1H, CH, 
J = 14.5 Hz), 3.78 (dd, 1H, CH, J = 17.0, 5.0 Hz), 3.9-4.2 (m, 3H, CH), 6.4-7.1 (m, 2H, H-Ar), 7.12 (t, 1Н, H-Ar, J 
= 9.3 Hz), 7.27 (t, 1H, H-Ar, J = 7.5 Hz), 7.49 (d, 2Н, H-Ar, J = 6.3 Hz); MS: m/z 396 (М+, 12.6%); Anal. Calcd. 
for C20H18F2N6O: C, 60.60; H, 4.58; N, 21.20. Found: C, 60.86; H, 4.70; N, 21.43. 
3-Amino-2-(4-chlorophenylazo)-3-[4-(3-chlorophenyl)-piperazin-1-yl]-acrylonitrile (12a). Colorless crystals 
(2.60 g, 65 %); mp 154-155 °С; 1Н NMR (250 MHz): δ 3.20-3.50 (m, 4H, СН2), 3.60-3.95 (m 4H, СН2), 6.74 (dd, 
1H, H-Ar, J = 7.4, 1.4 Hz), 6.85 (dd, 1H, H-Ar, J = 8.8, 2.0 Hz), 6.85-6.90 (m, 1H, H-Ar), 7.18 (dd, 1H, H-Ar, J = 
8.5, 1.9 Hz), 7.27 and 7.50 (AA′XX′, 4H, Н-Ar, J = 8.8 Hz), 7.60 (br s, 2H, NH2); MS: m/z (%) 401 (М+, 13.5%); 
Anal. Calcd. for С19Н18Cl2N6: C, 56.87; H, 4.52; N, 20.94. Found: C, 56.62; H, 4.43; N, 20.51. 
3-Amino-2-(4-chlorophenylazo)-3-[4-(3-methoxyphenyl)-piperazin-1-yl]-acrylo-nitrile (12b). Yellow crystals 
(3.05 g, 77 %); mp 178-179 °С; 1Н NMR (250 MHz): δ 3.08-3.28 (m, 4H, 2СН2), 3.66-3.88 (m, 4H, 2СН2), 3.71 (s 
3H, OMe), 6.85-6.90 (m, 1H, H-Ar), 6.78 (d, 2H, H-Ar, J = 8.8 Hz), 7.16 (d, 1H, H-Ar, J = 8.9 Hz), 7.27 and 7.50 
(AA′XX′, 4H, Н-Ar, J = 8.5 Hz), 7.56 (br s, 2H, NH2); MS: m/z (%) 396 (М+, 18.3%); Anal. Calcd. for 
С20Н21ClN6О: C, 60.53; H, 5.33; N, 21.18. Found: C, 60.22; H, 5.49; N, 21.41. 
3-Amino-2-(4-chlorophenylazo)-3-(4-pyridin-2-yl-piperazin-1-yl)-acrylonitrile (12c). Yellow crystals (2.17 g, 
59%); mp 169-171 °С; 1Н NMR (250 MHz): δ 3.35 (br s, 4H, 2CH2), 3.63 (br s, 4H, 2CH2), 6.69 (t, 1H, H-Pyr, J = 
4.9 Hz), 6.85 (d, 1H, H-Pyr, J = 8.6 Hz), 7.28 (br s, 2H, NH2), 7.34 (t, 1H, H-Pyr, J = 8.4 Hz), 7.51 and 7.90 
(AA′XX′, 4H, Н-Ar, J = 8.8 Hz), 7.57 (t, 1H, H-Pyr, J = 4.9 Hz); MS: m/z (%) 367 (М+, 23.5%); Anal. Calcd. for 
С18Н18ClN7: C, 58.78; H, 4.93; N, 26.65. Found: C, 58.51; H, 4.71; N, 26.82. 
3-Amino-2-(4-chlorophenylazo)-3-(4-pyrimidin-2-yl-piperazin-1-yl)-acrylonitrile (12d). Yellow crystals (2.32 
g, 63%); mp 169-171 °С; 1Н NMR (250 MHz): δ 3.50-3.59 (m, 4H, 2CH2), 3.80-3.95 (m, 4H, 2CH2), 6.55 (t, 1H, 
H-Pyrim, J = 4.3 Hz), 7.50 and 7.85 (AA′XX′, 4H, Н-Ar, J = 9.3 Hz), 8.20 (d, 2H, H-Pyrim, J = 4.3 Hz), 7.22 (brs, 
2H, NH2), MS: m/z (%) 368 (М+, 16.5%); Anal. Calcd. for С17Н17ClN8: C, 55.36; H, 4.65; N, 30.38. Found: C, 
55.58; H, 4.80; N, 30.57. 
General procedure of synthesis of 5-amino-2-aryl-2H-[1,2,3]triazole-4-carbonitrile 13-22. To solution of 0.005 
mol amidine 3-8, 10-12 in 50 ml pyridine was added 1.3 g (0.011 mol) Cu(OAc)2. The contents were stirred and 
were heated at 60 ºC about 5-6 hours. Then, the reaction mixture was cooled and diluted with water. The precipitate 
was collected by filtration and crystallized from ethanol. 
2-(4-Methoxyphenyl)-5-methylamino-2H-[1,2,3]triazole-4-carbonitrile (13a). Grey solid (0.80 g, 70%); mp 
168-169 °С; IR (KBr): νmax 3380 (NH), 3000, 2950, 2920, 2840, 2810 (CH), 2230 (CN) cm-1; 1Н NMR (250 MHz): 
δ 2.89 (d, 3Н, NHMe, J = 5.0 Hz), 3.83 (s, 3Н, ОMe), 6.68 (q, 1Н, NH, J = 5.0 Hz), 6.99 and 7.83 (AA′XX′, H-Ar, 
4H, J = 8.9 Hz); MS: m/z (%) 229 (М+, 100%); Anal. Calcd. for С11Н11N5О: C, 57.63; H, 4.84; N, 30.55. Found: C, 
57.49; H, 4.75; N, 30.37.  
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5-Methylamino-2-phenyl-2H-[1,2,3]triazole-4-carbonitrile (13b). Grey solid (0.58 g 57%); mp 130-131 °С; IR 
(KBr): νmax 3380 (NH), 2950, 2910, 2880, 2810 (CH), 2240 (CN) cm-1; 1H NMR (250 MHz): δ 2.91 (d, 3Н, NHMe, 
J = 4.6 Hz), 6.76 (q, 1Н, NH, J = 4.6 Hz), 7.36 (t, 1Н, H-Ar, J = 7.3 Hz), 7.49 (t, 2Н, H-Ar, J = 7.3 Hz), 7.93 (d, 
2Н, H-Ar, J = 7.7 Hz); 13C NMR (100 MHz): δ 29.9, 106.4, 112.5, 118.3(2C), 128.2, 129.7 (2C), 138.4, 157.6; MS: 
m/z (%) 199 (М+, 100 %); Anal. Calcd. for С10Н9N5: C, 60.29; H, 4.55; N, 35.15. Found: C, 60.49; H, 4.38; N, 
35.35.  
5-Methylamino-2-(4-nitrophenyl)-2H-[1,2,3]triazole-4-carbonitrile (13c). Brown solid (1.16 g, 95%); mp 189-
90 °С; 1Н NMR (250 MHz): δ = 2.9 (d, 3H, Me, J = 3.5 Hz), 7.2 (br, 1H, NH), 8.1 and 8.3 (AA′XX′, H-Ar, 4H, J = 
8.9 Hz); Anal. Calcd. for С10Н8N6O2: C, 49.18; H, 3.30; N, 34.41. Found: C, 49.33; H, 3.48; N, 34.68. 
5-Cyclohexylamino-2-(4-methoxyphenyl)-2H-[1,2,3]triazole-4-carbonitrile (14a). Grey solid (1.25 g, 84%); mp 
153-155 °С; IR (KBr): νmax 3350 (NH), 2930, 2850 (CH), 2230 (CN) cm-1; 1Н NMR (250 MHz): δ 0.99-2.11 (m, 
10Н, 5СН2), 3.57-3.30 (m, 1Н, СН), 3.83 (s, 3Н, ОMe), 6.44-6.67 (d, 1Н, NH, J = 6.2 Hz), 7.00 and 7.81 (AA′XX′, 
4H, H-Ar, J = 9.3 Hz); 13C NMR (100 MHz): δ 24.5 (2С), 25.3, 32.2 (2С),52.34, 55.5, 105.5, 113.0, 114.7 (2С), 
120.0 (2С), 132.1, 156.0, 159.0; MS: m/z (%) 297 (М+, 100%); Anal. Calcd. for С16H19N5O: C, 64.63; H, 6.44; N, 
23.55. Found: C, 64.41; H, 6.28; N, 23.67. 
5-Cyclohexylamino-2-phenyl-2H-[1,2,3]triazole-4-carbonitrile (14b). Grey solid (0.99 g, 84%); mp 171-173 °С; 
IR (KBr): νmax 3350 (NH), 2930, 2850 (CH), 2230 (CN) cm-1; 1Н NMR (250 MHz): δ 1.20-1.45 (m, 5H, СН), 1.85-
1.60 (m, 3H, СН2), 1.90-2.15 (m, 2H, СН2), 3.56-3.34 (m, 1Н, СН), 6.67 (d, 1Н, NH, J = 8.0 Hz), 7.29-7.46 (m, 
1Н, H-Ar), 7.90 (d, 2Н, H-Ar, J = 7.9 Hz), 7.50 (t, 2Н, H-Ar, J = 7.5 Hz); 13C NMR (400 MHz): δ 24.6 (2C), 25.3, 
32.2 (2C), 52.4, 106.5, 112.8, 118.3 (2C), 128.2, 129.7 (2C), 138.4, 156.0; MS: m/z (%) 267 (М+, 53.8%); Anal. 
Calcd. for С15H17N5: C, 67.39; H, 6.41; N, 26.20. Found: C, 67.61; H, 6.28; N, 26.45. 
2-(4-Methoxyphenyl)-5-pyrrolidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (15a). Grey solid (1.25 g, 89%); mp 
126-127 °С; IR (KBr): νmax 3380 (NH), 2980, 2940, 2880, 2840, (CH), 2220 (CN) cm-1; 1Н NMR (400 MHz): δ 
1.94-1.99 (m, 4H, 2СН2), 3.47-3.52 (m, 4Н, 2СН2), 3.81 (s, 3H, OMe), 7.11 and 7.85 (AA′XX′, 4H, H-Ar, J = 9.3 
Hz); 13C NMR (100 MHz): δ 24.8 (2C), 48.2 (2C), 55.5, 104.8, 113.9, 114.8 (2C), 120.1 (2C), 132.0, 155.7, 159.2; 
MS: m/z (%) 269 (М+, 100%); Anal. Calcd. for С14Н15N5O: C, 62.44; H, 5.61; N, 26.00. Found: C, 62.31; H, 5.48; 
N, 26.31. 
2-Phenyl-5-pyrrolidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (15b). Grey solid (1.15 g, 95%); mp 102-103 °С; 
IR (KBr): νmax 3380 (NH), 2980, 2940, 2880 (CH), 2230 (CN) cm-1; 1Н NMR (250 MHz): δ 1.93-2.14 (m, 4H, 
2СН2), 3.36-3.68 (m, 4Н, 2СН2), 7.39 (t, 1Н, H-Ar, J = 7.5 Hz), 7.51 (t, 2Н, H-Ar, J = 7.5 Hz), 7.93 (d, 2Н, H-Ar, J 
= 6.5 Hz); 13C NMR (100 MHz): δ 25.0 (2C), 48.2 (2C), 105.7, 113.7, 118.4(2C), 128.4, 129.7, 138.3, 161.9 (2C); 
MS: m/z (%) 239 (М+, 100%); Anal. Calcd. for С13Н13N5: C, 65.26; H, 5.48; N, 29.27. Found: C, 65.01; H, 5.25; N, 
29.42. 
2-(4-Chlorophenyl)-5-pyrrolidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (15c). Grey solid (2.15 g, 78%); mp 132-
133 °С; 1Н NMR (250 MHz): δ 1.95-2.10 (m, 4H, 2СН2), 3.45-3.60 (m, 4Н, 2СН2), 7.51 and 7.91 (AA′XX′, 4H, H-
Ar, J = 8.8 Hz); MS: m/z (%) 273 (М+, 100%); Anal. Calcd. for С13Н12ClN5: C, 57.04; H, 4.42; N, 25.59. Found: C, 
56.81; H, 4.20; N, 25.82. 
2-(4-Fluorophenyl)-5-pyrrolidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (15d) White solid (1.0 g, 77%); mp 120-
121 °С; 1Н NMR (250 MHz): δ 2.05 (br s, 4H, 2СН2), 3.54 (br s, 4Н, 2СН2), 7.29 (m, 2H, H-Ar), 7.92 (m, 2H, H-
Ar); Anal. Calcd. for С13Н12FN5: C, 60.69; H, 4.70; N, 27.22. Found: C, 60.93; H, 4.550; N, 26.96.  
2-(3,5-Difluorophenyl)-5-pyrrolidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (15e). Grey-green solid (1.38 g, 
100%); mp 160-162 °С; 1Н NMR (250 MHz): δ 1.85 (br s, 4H, 2СН2), 3.54 (brs, 4Н, 2СН2), 7.0-7.25 (m, 1H, H-
Ar), 7.45-7.6 (m, 2H, H-Ar); Anal. Calcd. for С13Н11F2N5: C, 56.73; H, 4.03; N, 25.44. Found: C, 56.53; H, 4.20; N, 
25.62.  
2-(4-Methoxyphenyl)-5-piperidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (16a). Grey solid (1.36 g, 96%); mp 96-
97 °С; 1Н NMR (250 MHz): δ 1.67 (br s, 4H, 3CH2), 1.90-2.10 (m, 2H, СН2), 3.40-3.52 (m, 4Н, 2СН2), 3.84 (s, 
3H, Me), 7.01 and 7.83 (AA′XX′, 4H, H-Ar, J = 9.3 Hz); 13C NMR (100 MHz): δ 23.3, 24.3 (2C), 48.0 (2C), 55.5, 
106.1, 113.7, 114.7 (2C), 120.1 (2C), 131.9, 157.9, 159.3; MS: m/z (%) 283 (М+, 100%); Anal. Calcd. for 
С15Н17N5O: C, 63.59; H, 6.05; N, 24.72. Found: C, 63.73; H, 5.83; N, 24.21.  
2-(4-Chlorophenyl)-5-piperidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (16b). Grey solid (1.00 g, 78%); mp 84-
85 °С; 1Н NMR (250 MHz): δ 1.68 (br s, 6H, 3CH2), 3.40-3.50 (br s, 4Н, 2СН2), 7.52 and 7.91 (AA′XX′, 4H, H-
Ar, J = 8.3 Hz); 13C NMR (100 MHz): δ 23.3. 24.3 (2C), 47.9 (2C), 107.4, 113.4, 120.1 (2C), 129.7 (2C), 132.8, 
136.9, 157.8; MS: m/z (%) 287 (М+, 36%); Anal. Calcd. for С14Н14ClN5: C, 58.44; H, 4.90; N, 24.34. Found: C, 
58.63; H, 4.72; N, 24.65.  
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2-(4-Fluorophenyl)-5-piperidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (16c). Violet solid (0.72 g, 50%); mp 121-
122 °С; 1Н NMR (250 MHz): δ 1.61 (br s, 6H, 3CH2), 3.50 (br s, 4Н, 2СН2), 7.25-7.35 (m, 2H, H-Ar), 7.8-8.05 (m, 
2H, H-Ar); MS: m/z (%) 271 (М+, 36%); Anal. Calcd. for С14Н14FN5: C, 61.98; H, 5.20; N, 25.81. Found: C, 61.67; 
H, 4.96; N, 26.05. 271  
2-(3,5-Difluorophenyl)-5-piperidin-1-yl-2H-[1,2,3]triazole-4-carbonitrile (16d). Grey solid (1.4 g, 97%); mp 
130-131 °С; 1Н NMR (250 MHz): δ 1.63 (br s, 6H, 3CH2), 3.49 (br s, 4Н, 2СН2), 7.35 (t, 1H, H-Ar, J = 8.9 Hz), 
7.57 (d, 2H, H-Ar, J = 6.0 Hz); MS: m/z (%) 289 (М+, 36%); Anal. Calcd. for С14Н13F2N5: C, 58.13; H, 4.53; N, 
24.21. Found: C, 58.36; H, 4.65; N, 24.45.  
5-[2-(1H-Indol-3-yl)-ethylamino]-2-(4-methoxyphenyl)-2H-[1,2,3]triazole-4-carbonitrile (17a). Grey solid 
(1.54 g, 86%); mp 96-98 °С; IR (KBr): νmax 3400, 3360, (NH), 2960, 2930, 2860, 2840 (CH), 2230 (CN) cm-1; 1Н 
NMR (250 MHz): δ 3.04 (br s, 2H, CH2), 3.55 (br s, 2H, CH2), 3.83 (s, 3H, OMe), 6.80-7.19 (m, 5H, H-Ind+H-
Ar+NH), 7.32 (d, 2H, H-Ind, J = 7.0 Hz), 7.58 (d, 1H, H-Ind, J = 6.3 Hz), 7.83 (d, 2H, H-Ar, J = 7.8 Hz), 10.60 (br 
s, 1H, NH); 13C NMR (100 MHz): δ 24.8, 44.3, 55.5, 111.4, 111.6, 112.8 (2C), 114.7 (2C), 118.2 (2C), 119.9, 120.9 
(2C), 122.8, 127.2, 132.1, 136.2, 156.9, 159.0; MS: m/z (%) 358 (М+, 10.5%); Anal. Calcd. for C20H18N6O: C, 
67.03; H, 5.06; N, 23.45. Found: C, 67.31; H, 5.18; N, 23.58. 
4-{4-Cyano-5-[2-(1H-indol-3-yl)-ethylamino]-[1,2,3]triazol-2-yl}-benzoic acid ethyl ester (17b). Grey solid 
(1.24 g, 62%); mp 221-222 °С; 1Н NMR (400 MHz): δ 1.37 (t, 3H, Me, J = 7.2 Hz), 3.03 (t, 2H, CH2, J = 6.8 Hz), 
3.65 (dt, 2H, CH2, J = 6.5, 6.8 Hz), 4.30 (q, 2H, CH2, J = 7.2 Hz), 6.95 (t, 1H, H-Ind J = 6.8 Hz), 7.04 (t, 1H, H-Ind, 
J = 7.0 Hz), 7.12-7.16 (m, 1H, H-Ind), 7.33 (d, 1H, H-Ind, J = 8.3 Hz), 7.5-7.7 (m, 2H, NH+H-Ind), 7.45 and 7.87 
(AA′XX′, H-Ar, 4H, J = 8.5 Hz), 10.60 (br s, 1H, NH); MS: m/z (%) 400 (М+, 15.5%); Anal. Calcd. for 
C22H20N6O2: C, 65.99; H, 5.03; N, 20.99. Found: C, 65.68; H, 5.25; N, 21.28. 
2-(4-Fluorophenyl)-5-[2-(1H-Indol-3-yl)-ethylamino]-2H-[1,2,3]triazole-4-carbonitrile (17c). Grey solid (1.2 g, 
70%); mp 220-221 °С; 1Н NMR (400 MHz): δ 3.0 (br s, 2Н, СН2), 3.5 (br s, 2Н, СН2), 7.0-7.15 (m, 2H, H-Ind+H-
Ar), 7.2 (s, 1H, H-Ind), 7.25-7.65 (m, 4H, H-Ar+H-Ind), 7.60-7.63 (m, 1H, H-Ind), 7.90-7.97 (m, 2H, H-Ind+NH), 
10.8 (br s, 1H, NH); Anal. Calcd. for С19Н15FN6: C, 65.89; H, 4.37; N, 24.26. Found: C, 65.68; H, 4.55; N, 24.47. 
2-(3,5-Difluorophenyl)-5-[2-(1H-Indol-3-yl)-ethylamino]-2H-[1,2,3]triazole-4-carbonitrile (17d). Brown solid 
(1.70 g, 96%); mp 139-141 °С; 1Н NMR (400 MHz): δ 3.09 (t, 2Н, СН2, J = 7.0 Hz), 3.76 (br s, 2Н, СН2), 6.59 (br, 
1H, H-Ar), 6.90-7.1 (m, 3Н, H-Ind+H-Ar), 7.18 (brs, 1H, H-Ind), 7.30-7.60 (m, 4H, H-Ind+H-Ar+NH), 10.7 (brs, 
1H, NH); Anal. Calcd. for С19Н14F2N6: C, 62.63; H, 3.87; N, 23.07. Found: C, 62.41; H, 4.01; N, 23.32. 
2-(4-Methoxyphenyl)-5-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-a][1,5]diazocin-3-yl)-2H-
[1,2,3]triazole-4-carbonitrile (18a). Yellow crystals (2.93g, 75%); mp 148-150 °С; 1Н NMR (250 MHz): δ 2.03 
(br s, 2H, СН2), 2.65 (br s, 1Н, CH), 3.26 (br s, 1Н, CH), 3.39 (d, 2Н, CH, J = 13.0 Hz), 3.80 (br s, 1Н, CH), 3.82 
(s, 3Н, ОMe), 3.90-4.15 (m, 3Н, CH2), 6.15 (d, 2Н, H-Ar, J = 6.8 Hz), 6.98 and 7.75 (AA′XX′, 4H, H-Ar, J = 8.3 
Hz), 7.23 (t, 1H, H-Ar, J = 6.5 Hz); MS: m/z (%) 388 (М+, 7.5%); Anal. Calcd. for С21Н20N6О2: C, 64.94; H, 5.19; 
N, 21.64. Found: C, 64.67; H, 5.28; N, 21.63.  
5-(8-Oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-a][1,5]diazocin-3-yl)-2-phenyl-2H-[1,2,3]triazole-
4-carbonitrile (18b). Grey solid (1.31 g, 67%); mp 172-3 °С; 1Н NMR (400 MHz): δ 2.04 (s, 2H, CH2), 2.66 (s, 
1H, CH), 3.32 (m, 3H, CH), 3.78 (dd, 1H, CH, J = 15.0, 14.0 Hz), 4.1 (m, 3H, CH), 6.16 (d, 2H, H-Ar, J = 7.5 Hz), 
7.27 (dd, 1H, CH J = 7.5, 8.0 Hz), 7.51 and 7.87 (AA′XX′, 4H, H-Ar, J = 8.5 Hz); Anal. Calcd. for С20Н18N6О: C, 
67.03; H, 5.06; N, 23.45. Found: C, 67.33; H, 4.83; N, 23.57.  
2-(4-Fluorophenyl)-5-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-a][1,5]diazocin-3-yl)-2H-
[1,2,3]triazole-4-carbonitrile (18d). Grey solid (1.35 g, 72%); mp 107-109 °С; 1Н NMR (250 MHz): δ 2.04 (br s, 
2Н, СН2), 2.65 (br s, 1Н, СН), 3.25-3.40 (m, 3Н, CН), 3.90 (d, 1Н, СН, J = 15.5, 6.3 Hz), 3.85-4.05 (m, 2Н, СН), 
4.11 (d, 1H, CH, J = 13.0 Hz), 6.16 (d, 2Н, H-Ar, J = 7.0 Hz), 7.24-7.31 (m, 3Н, H-Ar), 7.87-7.93 (m, 2Н, H-Ar); 
13С NMR (100 MHz): δ 24.3, 26.4, 33.3, 48.9, 53.4, 54.5, 104.6, 107.0, 113.0, 115.9, 116.5 (d, 2C, J = 23.4 Hz), 
120.9 (d, 2C, J = 8.9 Hz), 134.6, 138.9, 149.9, 157.7, 161.6 (d, J = 244.8 Hz), 162.0; MS: m/z (%) 376 (М+, 25); 
Anal. Calcd. for С20Н17FN6О: C, 63.82; H, 4.55; N, 22.33. Found: C, 63.57; H, 4.28; N, 22.21. 
2-(2,4-Dichlorophenyl)-5-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methano-pyrido[1,2-a][1,5]diazocin-3-yl)-2H-
[1,2,3]triazole-4-carbonitrile (18e). Grey solid (1.62 g, 76%); mp 138-139 °С; 1Н NMR (250 MHz): δ 2.04 (br s, 
2H, CH), 2.63 (br s, 1H, CH), 3.3-3.45 (m, 3H, CH), 3.65-3.72 (m, 1H, CH), 3.9-4.2 (m, 3H, CH), 6.14 (d, 2H, H-
Ar, J = 7.0 Hz), 7.26 (t, 1H, HAr, J = 7.0 Hz), 7.53 (d, 1H, H-Ar, J = 8.0 Hz), 7.60-7.75 (m, 2H, H-Ar); MS: m/z 
(%) 427 (М+, 26.4%); Anal. Calcd. for С20Н16Cl2N6О: C, 56.22; H, 3.77; N, 19.67. Found: C, 56.47; H, 3.58; N, 
19.43. 
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2-(3,5-Difluorophenyl)-5-(8-oxo-1,5,6,8-tetrahydro-2H,4H-1,5-methanopyrido[1,2-a][1,5]diazocin-3-yl)-2H-
[1,2,3]triazole-4-carbonitrile (18f). Grey solid (1.35 g, 72%); mp 107-109 °С; 1Н NMR (250 MHz): δ 2.04 (br s, 
2Н, СН2), 2.65 (br s, 1Н, СН), 3.25-3.40 (m, 3Н, CН), 3.90 (d, 1Н, СН, J = 15.5, 6.3 Hz), 3.85-4.05 (m, 2Н, СН), 
4.11 (d, 1H, CH, J = 13.0 Hz), 6.16 (d, 2Н, H-Ar, J = 7.0 Hz), 7.24-7.31 (m, 3Н, H-Ar), 7.87-7.93 (m, 2Н, H-Ar); 
13С NMR (100 MHz): δ 24.3, 26.4, 33.3, 48.9, 53.4, 54.5, 102.6 (d, 2C J = 20.9 Hz), 103.9 (t, J = 24.8 Hz), 104.6, 
108.3, 113.0, 115.9, 138.9, 139.6 (t, 2C, J = 13.3 Hz), 149.9, 157.7, 161.6 (d, J=244.8 Hz), 162.0; MS: m/z (%) 394 
(М+, 25%); Anal. Calcd. for С20Н16F2N6О: C, 60.91; H, 4.09; N, 21.31. Found: C, 60.73; H, 4.28; N, 21.07. 
2-(4-Chlorophenyl)-5-[4-(3-chlorophenyl)-piperazin-1-yl]-2H-[1,2,3]triazole-4-carbonitrile (19). Grey solid 
(1.30 g, 65%); mp 154-155 °С; 1Н NMR (250 MHz): δ 3.19-3.43 (m, 4H, 2СН2), 3.43-3.65 (m, 4H, 2СН2), 6.78 (d, 
1H, H-Ar, J = 7.8 Hz), 6.90 (d, 1H, Н-Ar, J = 8.2 Hz), 6.90-7.0 (m, 1H, H-Ar), 7.19 (dd, 1H, H-Ar, J = 8.0, 1.9 Hz), 
7.54 and 7.95 (AA'XX,' 4H, H-Ar, J = 8.3 Hz) 7; MS: m/z (%) 399 (М+, 23%); Anal. Calcd. for С19Н16Cl2N6: C, 
57.16; H, 4.04; N, 21.05. Found: C, 57.38; H, 4.25; N, 21.36. 
2-(4-Chlorophenyl)-5-[4-(3-methoxyphenyl)-piperazin-1-yl]-2H-[1,2,3]triazole-4-carbonitrile (20). Grey solid 
(0.91 g, 55%); mp 170-171 °С; 1Н NMR (250 MHz): δ 3.31-3.35 (m, 4H, 2СН2), 3.63-3.67 (m, 4H, 2СН2), 3.75 (s, 
3H, OMe), 6.36 (dd, 1H, H-Ar, J = 7.8, 2.1 Hz), 6.47-6.50 (m, 1H, Н-Ar), 6.55 (dd, 1H, H-Ar, J = 8.3, 1.8 Hz), 7.10 
(dd, 1H, H-Ar, J = 8.3, 1.8 Hz), 7.54 and 7.96 (AA'XX,' 4H, H-Ar, J = 8.5 Hz); MS: m/z (%) 394 (М+, 45%); Anal. 
Calcd. for С20Н19ClN6O: C, 60.84; H, 4.85; N, 21.28. Found: C, 60.57; H, 4.95; N, 21.47. 
2-(4-Chlorophenyl-5-(4-pyridin-2-yl-piperazin-1-yl)-2H-[1,2,3]triazole-4-carbonitrile 21. Grey solid (1.50 g, 
90%); mp 146-148 °С; 1Н NMR (250 MHz): δ 3.58-3.61 (m, 4H, 2CH2), 3.69-3.72 (m, 4H, 2CH2), 6.69 (t, 1H, H-
Pyr, J = 4.9 Hz), 6.92 (d, 1H, H-Pyr, J = 5.0 Hz), 7.58 (t, 1H, H-Ar, J = 7.4 Hz), 7.65 and 7.98 (AA'XX,' 4H, H-Ar, 
J = 9.0 Hz), 7.57 (t, 1H, H-Pyr, J = 4.9 Hz); 13С NMR (100 MHz): δ 43.7 (2С), 46.7 (2С), 107.4, 107.8, 113.3. 
113.5, 118.6 (2C), 128.7, 129.8 (2C), 137.6, 138.2, 147.6, 157.8, 158.7; MS: m/z (%) 365 (М+, 35%); Anal. Calcd. 
for С18Н16ClN7: C, 59.10; H, 4.41; N, 26.80. Found: C, 59.35; H, 4.65; N, 26.57. 
2-(4-Chlorophenyl-5-(4-pyrimidin-2-yl-piperazin-1-yl)-2H-[1,2,3]triazole-4-carbonitrile 22. Grey solid (1.55 g, 
85%); mp 116-117 °С; 1Н NMR (250 MHz): δ 3.52-3.61 (m, 4H, 2CH2), 3.95-3.99 (m, 4H, 2CH2), 6.61 (t, 1H, H-
Pyrim, J = 4.3 Hz), 7.54 and 7.95 (AA'XX,' 4H, H-Ar, J = 8.8 Hz), 8.33 (d, 2H, H-Pyrim, J = 4.3 Hz); MS: m/z (%) 
366 (М+, 54.5%); Anal. Calcd. for С17Н15ClN8: C, 55.67; H, 4.12; N, 30.55. Found: C, 55.45; H, 4.25; N, 30.27. 
 
Fungicide Screening Method. Using the fungi growth inhibition method for fungicide activity determination.11 A 
solution of the compound in a concentration of 500 mg/mL was dissolved in water assisted by DMF (0.1mL) and 
then 50 µg/mL of the compound was placed on an agar plate, the fungi were inoculated and cultured in the culture 
tank at 24 oC-26 oC. The diameter of the fungi spread was measured two days later, and the growth inhibition was 
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